Episode 2: We Don't Talk About Rylaze

from WolverHeme Happy Hour · host Bernard Marini, Anthony Perissinotti, et al.

Bernie Marini and Anthony Perissinotti discuss asparaginase, the data (or lack thereof) behind the FDA approval of Rylaze (Erwinia asparaginase), and concerning trends regarding switches between asparaginase products in clinical practice! 

Episode metadata supplied by the publisher feed · Published Mar 18, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 2: We Don't Talk About Rylaze

0:00 44:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of WolverHeme Happy Hour?

This episode is 44 minutes long.

When was this WolverHeme Happy Hour episode published?

This episode was published on March 18, 2022.

Can I download this WolverHeme Happy Hour episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!